About MedicQuant ApS
MedicQuant ApS is a company based in Aarhus (Denmark) founded in 2019 by Kurt Gothelf, Line Debois, and Malthe Hansen Bruhn. The company has 7 employees as of November 30, 2024. MedicQuant ApS offers products and services including DOAC Detection Instrument. MedicQuant ApS operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Entegrion, Enzyre and Perosphere, among others.
- Headquarter Aarhus, Denmark
- Employees 7 as on 30 Nov, 2024
- Founders Kurt Gothelf, Line Debois, Malthe Hansen Bruhn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medicquant Aps
-
Annual Revenue
Not available
-
Net Profit
-$37.68 K (USD)-455as on Dec 31, 2022
-
EBITDA
-$48.31 K (USD)-555as on Dec 31, 2022
-
Latest Funding Round
$81.91 K (USD), Grant
Jul 01, 2023
- Investors
-
Employee Count
7
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedicQuant ApS
MedicQuant ApS offers a comprehensive portfolio of products and services, including DOAC Detection Instrument.
Rapid tool for detecting anticoagulants in whole blood within 10 minutes.
Funding Insights of MedicQuant ApS
Investors in MedicQuant ApS
MedicQuant ApS has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for MedicQuant ApS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedicQuant ApS
Investment portfolio details for MedicQuant ApS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedicQuant ApS
Detailed financials for MedicQuant ApS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medicquant Aps Comparisons
Peer comparison for MedicQuant ApS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedicQuant ApS
MedicQuant ApS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Entegrion, Enzyre and Perosphere, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| Locked | Locked | Locked |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| Locked | Locked | Locked |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| Locked | Locked | Locked |
Smart diagnostics devices for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
Detailed competitors of MedicQuant ApS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medicquant Aps
Complete news archive for MedicQuant ApS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedicQuant ApS
MedicQuant ApS was founded in 2019 and raised its 1st funding round 1 year after it was founded.
MedicQuant ApS is headquartered in Aarhus, Denmark.
Line Debois is the current CEO of MedicQuant ApS. They have also founded this company.
As of Nov 30, 2024, the latest employee count at MedicQuant ApS is 7.
MedicQuant ApS was founded in 2019 in Aarhus, Denmark, within the medtech sector. Diagnostic kits for assessing blood anticoagulant properties are developed and supplied by the company. A chip and instrument are utilized to detect anticoagulants directly from whole blood samples. Operations focus on enabling point-of-care testing for healthcare applications, with co-founders including Line Debois as CEO.
MedicQuant ApS's top competitors include Accriva Diagnostics, Diagnostica Stago and Enzyre.
MedicQuant ApS offers DOAC Detection Instrument.
MedicQuant ApS has 1 investor. Key investors include European Union.
The valuation of MedicQuant ApS is $23.18K as of Oct 2021.